Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Post by oiljack14on Aug 24, 2020 3:35pm
243 Views
Post# 31447167

Revenue and Impairment Study....largest on the planet

Revenue and Impairment Study....largest on the planetYou guys know the successful Cannabis impairment study in India as over seen by IIT and having tested 3,000 to 3,500 people is being disseminated to academic journals for validation and then will be used to leverage North American and work place safety contracts and ring fence the technology against potential legal challenges as a result of being the world's largest cannabis impairment study and having clinical experts validate it right.

Oops.....did I just give away a news release bi-line. I'm sorry


Indian National Oil Co is utilizing it because it.....****ing works baby! Period!

Revenue works like this. A limited trial period of provability goes on...three to four months...and then the contracts automatically escalate to a pay per use model. Algo8 and PMED are NOT charities. Oops....did I scoop another NR. Man what an a$$ I am. Much to show yet. Count on it
<< Previous
Bullboard Posts
Next >>